Quantcast

Bioidentical Hormone Initiative to Host Monthly 6 CME Approved Seminar in New York City

February 7, 2012

The Bioidentical Hormone Initiative (BHI) today announced its second in the monthly series of seminars on the Clinical Application of BHRT (bioidentical hormone replacement therapies) providing participants with 6 Category 1 AMA PRA CME credits approved by SUNY-Downstate Medical Center.
The seminar will take place in New York City on Saturday, February 25, at 200 West 57 Street, Suite 408. Registration is limited to 30 participants.

New York, New York (PRWEB) February 07, 2012

The Bioidentical Hormone Initiative (BHI) today announced its second in the monthly series of seminars on the Clinical Application of BHRT (bioidentical hormone replacement therapies) providing participants with 6 Category 1 AMA PRA CME credits approved by SUNY-Downstate Medical Center.

The seminar will take place in New York City on Saturday, February 25, at 200 West 57 Street, Suite 408. Registration is limited to 30 participants.

“This 6 AMA PRA CATEGORY 1 CREDITS approved course by SUNY- Downstate College of Medicine is a highly educational and rewarding seminar for practicing physicians interested in helping their patients stay healthy by creating hormone balance” said Cheryl Perlis, MD a gynecologist from Chicago who participated in the January 28 seminar.

The mini course is a highly sought after intensive one-day practitioner education opportunity that covers the clinical application of BHRT, insurance issues, testing, diagnosis, clinical protocols for men and women, dosage titration and extensive review of case studies.

The presenters who are key opinion leaders in the field, Erika Schwartz, MD and Joseph Raffaele, MD will also discuss the latest medical evidence presented at the International Menopause Society World Congress. “We are thrilled to be able to provide CME certification to our physician participants. Hormone therapies and age management are topics all physicians must become expert in and post-graduate training is the best way to do so.” says Dr. Erika Schwartz.

Four hours will be devoted to individual participant discussion and questions of relevant hormone issues encountered in clinical practice.

ACCREDITATION STATEMENT This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the State University of New York (SUNY) Downstate Medical Center and the Bioidentical Hormone Initiative.

The State University of New York (SUNY) Downstate Medical Center designates this live activity for a maximum of 6 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE STATEMENT SUNY Downstate Medical Center Office of CMOCME) and its affiliates are committed to providing educational activities that are objective, balaned and as free of bias as possible. The OCME has established policies that will identify and resolve all conflicts of interest prior to this educational activity. All participating faculty are expected to disclose to the audience, verbally or in writing, any commercial relationships that might be perceived as a real or apparent conflict of interest related to the content of their presentations, and unlabeled/unapproved uses of drugs and devices. Detailed disclosures will be made verbally and/or in writing during the program.

ADA STATEMENT Special Needs: In accordance with the Americans with Disabilities Act, SUNY Downstate Medical Center seeks to make this conference accessible to all. If you have a disability which might require special accommodations, please contact Gene Calderon, or e-mail your needs to: support(at)bioidenticalhormoneinitiative(dot)org

###

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/2/prweb9168918.htm


Source: prweb



comments powered by Disqus